
Articles
-
1 week ago |
millenniumpost.in | Latha Jishnu
Patent battle over rare disease drugs puts affordability and access at the heart of India’s public health debateWe will begin with a standout paragraph in a recent judgment on a case involving access to life-saving medicines. Public health, it said, is not something that should be dealt with lightly.
-
1 week ago |
hindi.downtoearth.org.in | Latha Jishnu
हाल ही में एक प्रमुख समाचार पत्र ने पेटेंट पर एक वैचारिक लेख प्रकाशित किया था जिसमें एक चौंकाने वाले प्रस्ताव की सिफारिश की गई थी। लेखक का कहना था कि भारत में पेटेंट का संस्कृत भाषा में भी पंजीकरण कराया जाना चाहिए। ध्यान रहे कि वर्तमान में यह केवल हिंदी एवं अंग्रेजी में होता है। लेखक ने दावा किया कि इससे भारत की तकनीकी प्रगति तो सुरक्षित रहेगी ही और साथ ही हमारी सांस्कृतिक विरासत की भी पुष्टि होगी। इतिहास में संस्कृत की भूमिका के बारे में उत्साहित होकर वह लिखते हैं कि जटिल ज्ञान प्रणालियों को...
-
2 weeks ago |
downtoearth.org.in | Latha Jishnu
We will begin with a standout paragraph in a recent judgement on a case involving access to life-saving medicines. Public health, it said, is not something that should be dealt with lightly.
-
4 weeks ago |
millenniumpost.in | Latha Jishnu
Trump’s plan to levy duties on pharma violates WTO rules, but there is no recourse as the trade regulator is dysfunctionalUS President Donald Trump’s shock decision to impose tariffs on pharmaceuticals from April has put the spotlight on one of the most worrisome problems in international commerce—the absence of a global trade regulator.
-
1 month ago |
downtoearth.org.in | Latha Jishnu
US President Donald Trump’s shock decision to impose tariffs on pharmaceuticals from April has put the spotlight on one of the most worrisome problems in international commerce—the absence of a global trade regulator. The World Trade Organization (WTO) has been dying a slow death over the past decade, and even its most trenchant critics have been troubled by the deliberate attempt of the US, which, ironically, championed its formation, to shackle the apex trade regulatory body.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →